Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to Clover Health's second quarter 2026 earnings call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question and answer session. Also, as a reminder, this conference is being recorded today. If you have any objections, please disconnect this time. Ryan, you may begin. Good afternoon, everyone. Joining me on our call today to discuss the company's second quarter 2026 results are Andrew Toy, Clover Health's chief executive officer, and Clay Thornton, the company's interim chief financial officer. You can find today's press release and the accompanying supplemental slides, as well as the company's most recent investor deck and the investor events and presentation section of our website at investors.cloverhealth.com. This webcast is being recorded and a replay will be available in the investor relations section of the Clover Health website. I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties, including expectations about future performance. Factors that may cause actual results to differ materially from expectations are detailed in our SEC filings, including in the risk factors section of our most recent annual report on Form 10-K and other SEC filings. Thank you, Ryan. And thanks, everyone, for joining our call today. Thank you so much for joining us. The first half of 2026 was another important proof point of this. Through the first six months of the year, we delivered market-leading MA membership growth of 48% while increasing gap net income by $67 million year over year. At the same time, total revenue in the first half increased by more than $550 million year over year to $...